ArticleClinical journal of gastroenterology2026
Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors.
Sho Tazuma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.